Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Genprex Inc (NQ: GNPX )

3.920 USD +0.170 (+4.53%)
Official Closing Price Updated: 7:33 PM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Genprex Inc

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Slated to Present Trailblazing Gene Therapies at the MoneyShow Accredited Investors Virtual Expo
From InvestorBrandNetwork
Genprex to Present its Cutting-Edge Gene Therapies at the MoneyShow Accredited Investors Virtual Expo
Genprex's CEO will present at the MoneyShow Virtual Conference on January 28. 
From Business Wire News Releases
BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Slated to Present at NobleCon17
From InvestorBrandNetwork
Genprex to Present at NobleCon17 on January 19
Genprex CEO will present at NobleCon on January 19 at 3:45 pm ET 
From Business Wire News Releases
BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Passes Final Release Tests for Manufacturing Run of Proprietary Immunogene Therapy Treatment
From InvestorBrandNetwork
Genprex Achieves Major Manufacturing Milestone for REQORSA™ Immunogene Therapy for Upcoming Trials to Treat Non-Small Cell Lung Cancer
Genprex Successfully Completes Manufacturing for REQORSA and Passes All Testing 
From Business Wire News Releases
BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Secures $12M in Registered Direct Offering
From InvestorBrandNetwork
70 Biggest Movers From Thursday
Gainers Air T, Inc. (NASDAQ: AIRT) shares jumped 293.6% to close at $38.38 on Thursday after the company announced plans to form a ... 
Tags ALGS EYES ODT
From Benzinga
5 Biotech Stocks That Generated 1,000%+ Returns In 2020
The biopharma sector weathered the COVID-19 pandemic fairly well, with the Shares Nasdaq Biotechnology ETF IBB outperforming the S&P 500 Index. Here are the biotechs that advanced in excess of 1,000%... 
Tags Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
5 Biotech Stocks That Generated 1,000%+ Returns In 2020
The biopharma sector weathered the COVID-19 pandemic fairly well, with the Shares Nasdaq Biotechnology Etf (NASDAQ: IBB) outperforming ... 
Tags Movers IBB Benzinga
From Benzinga
Genprex, Inc. Announces Closing Of $12 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules Without Warrants
Genprex announces $12 million registered direct closing. 
From Business Wire News Releases
88 Biggest Movers From Yesterday
Gainers Ocugen, Inc. (NASDAQ: OCGN) shares climbed 222.9% to close at $2.60 on Wednesday after the company announced it will ... 
Tags JAGX Benzinga UUUU
From Benzinga
BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Enters into Estimated $12-Million Securities Purchase Agreement
From InvestorBrandNetwork
88 Biggest Movers From Yesterday
Gainers Ocugen Inc (NASDAQ: OCGN) shares surged 173.9% to close at $0.8052 on Tuesday after the company and Bharat Biotech ... 
Tags MARA IAC CLW
From Benzinga
Genprex, Inc. Announces $12 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules, Without Warrants
Genprex, Inc. (Nasdaq: GNPX) (“Genprex” or the “Company”), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced it... 
From Business Wire News Releases
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Ocugen (NASDAQ:OCGN) stock moved upwards by 141.83% to $0.71 during Tuesday's regular session. As of 12:31 ... 
Tags Movers EYES OCGN
From Benzinga
61 Stocks Moving In Tuesday's Mid-Day Session
Gainers Big Rock Partners Acquisition Corp. (NASDAQ: BRPA) shares jumped 202% to $74.37 after jumping over 60% on Monday. Ocugen ... 
Tags LPTH POLA AHT
From Benzinga
BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Reaches Another Significant Milestone with Scaled-up Production of Clinical-Grade REQORSA(TM)
From InvestorBrandNetwork
Genprex's Leading Drug Candidate Is Currently Being Developed As A Treatment For Lung Cancer
Genprex was one of the sponsors for the Benzinga Global Small Cap Conference that took place on December 8-9, 2020. According to data ... 
Tags Benzinga Genprex General
From Benzinga
Genprex Completes Manufacturing Scale-Up for Clinical-Grade Production of REQORSA™ Immunogene Therapy for Upcoming Acclaim-1 and Acclaim-2 Clinical Trials For Lung Cancer
Genprex completes clinical-grade manufacturing of lead drug candidate, REQORSA 
From Business Wire News Releases
Benzinga Global Small Cap Conference Day 1 Recap: Sorrento, Arcimoto And Much More
The inaugural Benzinga Global Small Cap Conference kicked off on Tuesday with presentations from several CEOs and industry experts. Over ... 
Tags 2020 election Events Benzinga events
From Benzinga
BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Finalizes Technology Transfer of Manufacturing Process for Novel Gene Therapy
From InvestorBrandNetwork
Genprex Completes Manufacturing Technology Transfer for Novel Gene Therapy
Genprex completes major manufacturing milestone with completion of technology transfer 
From Business Wire News Releases
BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) to Present Overview, Clinical Trial Update at Upcoming Benzinga Conference
From InvestorBrandNetwork
Genprex to Present at the Benzinga Global Small Cap Conference on December 8
Genprex's President and CEO will present at the Benzinga Conference on Dec. 8, 2020 at 2:30 p.m. ET 
From Business Wire News Releases
BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Commences Site Recruitment for Upcoming Acclaim-1 Clinical Trial
From InvestorBrandNetwork
Genprex Initiates Site Recruitment for Acclaim-1 Clinical Trial for the Treatment of Non-Small Cell Lung Cancer
Genprex commences clinical trial site recruitment for Acclaim-1 clinical trial 
From Business Wire News Releases
BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) to Present at Diamond Equity Research Emerging Growth Invitational
From InvestorBrandNetwork
Diamond Equity Research 2020 Virtual Emerging Growth Invitational
From ACCESSWIRE
Genprex to Participate at the Diamond Equity Research Emerging Growth Invitational on December 1
Genprex's COO will present on December 1 at the Diamond Equity Research Emerging Growth Invitational 
From Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.